These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21047671)

  • 61. Expert consensus for performing right heart catheterisation for suspected pulmonary arterial hypertension in systemic sclerosis: a Delphi consensus study with cluster analysis.
    Avouac J; Huscher D; Furst DE; Opitz CF; Distler O; Allanore Y;
    Ann Rheum Dis; 2014 Jan; 73(1):191-7. PubMed ID: 23349131
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Systemic scleroderma: Review and updated approach and case description to addressing pulmonary arterial hypertension and idiopathic pulmonary fibrosis: A dual challenge in treatment.
    Cueto-Robledo G; Tovar-Benitez D; Alfaro-Cruz A; Gonzalez-Hermosillo LM
    Curr Probl Cardiol; 2024 Apr; 49(4):102404. PubMed ID: 38232920
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis.
    Yaqub A; Chung L
    Curr Rheumatol Rep; 2013 Jan; 15(1):302. PubMed ID: 23292818
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pulmonary veno-occlusive disease: a probably underdiagnosed cause of pulmonary hypertension in systemic sclerosis.
    Duarte AC; Cordeiro A; Loureiro MJ; Ferreira F
    Clin Rheumatol; 2020 May; 39(5):1687-1691. PubMed ID: 31965379
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pulmonary Hypertension: How to Best Treat the Different Scleroderma Phenotypes?
    Korman BD; Lachant DJ; Castelino FV
    Rheum Dis Clin North Am; 2023 May; 49(2):345-357. PubMed ID: 37028839
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sclerosing panniculitis is associated with pulmonary hypertension in systemic sclerosis.
    Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K
    Br J Dermatol; 2005 Sep; 153(3):579-83. PubMed ID: 16120146
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Systemic sclerosis].
    Schinke S; Riemekasten G
    Internist (Berl); 2019 Dec; 60(12):1251-1269. PubMed ID: 31754753
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Imaging lung disease in systemic sclerosis.
    Strollo D; Goldin J
    Curr Rheumatol Rep; 2010 Apr; 12(2):156-61. PubMed ID: 20425026
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Usefulness of six-minute walk test in systemic sclerosis.
    Rizzi M; Radovanovic D; Santus P; Airoldi A; Frassanito F; Vanni S; Cristiano A; Sarzi-Puttini P; Atzeni F
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):161-167. PubMed ID: 30277863
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.
    Shahane A
    Rheumatol Int; 2013 Jul; 33(7):1655-67. PubMed ID: 23334373
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lung disease in systemic sclerosis (scleroderma).
    Bolster MB; Silver RM
    Baillieres Clin Rheumatol; 1993 Feb; 7(1):79-97. PubMed ID: 8519079
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targets.
    Dimitroulas T; Giannakoulas G; Karvounis H; Settas L; Kitas GD
    Curr Pharm Des; 2012; 18(11):1457-64. PubMed ID: 22364130
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Systemic sclerosis complicated by arrhythmogenic right ventricular dysplasia that was misinterpreted as pulmonary arterial hypertension.
    Arai S; Kurasawa K; Maezawa R; Hanaoka R; Fukuda T
    Mod Rheumatol; 2012 Feb; 22(1):152-7. PubMed ID: 21706262
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: The Johns Hopkins Registry.
    Hassan HJ; Naranjo M; Ayoub N; Housten T; Hsu S; Balasubramanian A; Simpson CE; Damico RL; Mathai SC; Kolb TM; Hassoun PM
    Am J Respir Crit Care Med; 2023 Feb; 207(3):312-322. PubMed ID: 36173815
    [No Abstract]   [Full Text] [Related]  

  • 75. Pulmonary involvement in systemic sclerosis: exploring cellular, genetic and epigenetic mechanisms.
    Doskaliuk B; Zaiats L; Yatsyshyn R; Gerych P; Cherniuk N; Zimba O
    Rheumatol Int; 2020 Oct; 40(10):1555-1569. PubMed ID: 32715342
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis.
    Ntelis K; Solomou EE; Sakkas L; Liossis SN; Daoussis D
    Semin Arthritis Rheum; 2017 Dec; 47(3):409-417. PubMed ID: 28602360
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mechanism of disease: Pulmonary hypertension.
    Farber HW; Loscalzo J
    Discov Med; 2005 Feb; 5(25):80-7. PubMed ID: 20704929
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension.
    Ruiter G; Lanser IJ; de Man FS; van der Laarse WJ; Wharton J; Wilkins MR; Howard LS; Vonk-Noordegraaf A; Voskuyl AE
    Rheumatology (Oxford); 2014 Feb; 53(2):285-92. PubMed ID: 24155365
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pulmonary hypertension in systemic sclerosis.
    Denton CP; Black CM
    Rheum Dis Clin North Am; 2003 May; 29(2):335-49, vii. PubMed ID: 12841298
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Associated factors of early-onset pulmonary hypertension and clinical difference between early- and late-onset pulmonary hypertension in Thai systemic sclerosis.
    Krikeerati T; Pussadhamma B; Mahakkanukrauh A; Suwannaroj S; Nanagara R; Foocharoen C
    Mod Rheumatol; 2021 May; 31(3):649-656. PubMed ID: 32924684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.